HRP20030126B1 - Selective cyclic peptides - Google Patents
Selective cyclic peptidesInfo
- Publication number
- HRP20030126B1 HRP20030126B1 HR20030126A HRP20030126A HRP20030126B1 HR P20030126 B1 HRP20030126 B1 HR P20030126B1 HR 20030126 A HR20030126 A HR 20030126A HR P20030126 A HRP20030126 A HR P20030126A HR P20030126 B1 HRP20030126 B1 HR P20030126B1
- Authority
- HR
- Croatia
- Prior art keywords
- carbon atoms
- hydrogen
- alkyl
- bond
- cyclic peptides
- Prior art date
Links
- 102000001189 Cyclic Peptides Human genes 0.000 title 1
- 108010069514 Cyclic Peptides Proteins 0.000 title 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 11
- 229910052739 hydrogen Inorganic materials 0.000 abstract 10
- 239000001257 hydrogen Substances 0.000 abstract 10
- 125000000217 alkyl group Chemical group 0.000 abstract 6
- 150000002431 hydrogen Chemical group 0.000 abstract 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000001475 halogen functional group Chemical group 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/64—Cyclic peptides containing only normal peptide links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
- C07K14/68—Melanocyte-stimulating hormone [MSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22918400P | 2000-08-30 | 2000-08-30 | |
| PCT/EP2001/009630 WO2002018437A2 (en) | 2000-08-30 | 2001-08-21 | Cyclic peptides having melanocortin-4 receptor agonist activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HRP20030126A2 HRP20030126A2 (en) | 2005-10-31 |
| HRP20030126B1 true HRP20030126B1 (en) | 2009-01-31 |
Family
ID=22860145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20030126A HRP20030126B1 (en) | 2000-08-30 | 2003-02-20 | Selective cyclic peptides |
Country Status (35)
| Country | Link |
|---|---|
| US (1) | US7045591B2 (cs) |
| EP (1) | EP1315750B1 (cs) |
| JP (1) | JP4217069B2 (cs) |
| KR (1) | KR100483300B1 (cs) |
| CN (1) | CN100491396C (cs) |
| AR (2) | AR030504A1 (cs) |
| AT (1) | ATE353918T1 (cs) |
| AU (2) | AU8402601A (cs) |
| BR (1) | BR0113637A (cs) |
| CA (1) | CA2420058C (cs) |
| CY (1) | CY1106562T1 (cs) |
| CZ (1) | CZ2003584A3 (cs) |
| DE (1) | DE60126624T2 (cs) |
| DK (1) | DK1315750T3 (cs) |
| EC (1) | ECSP034503A (cs) |
| ES (1) | ES2280393T3 (cs) |
| HR (1) | HRP20030126B1 (cs) |
| HU (1) | HUP0303078A3 (cs) |
| IL (2) | IL154575A0 (cs) |
| JO (1) | JO2454B1 (cs) |
| MA (1) | MA27681A1 (cs) |
| MX (1) | MXPA03001721A (cs) |
| MY (1) | MY137457A (cs) |
| NO (1) | NO20030916L (cs) |
| NZ (1) | NZ523989A (cs) |
| PA (1) | PA8527201A1 (cs) |
| PE (1) | PE20020483A1 (cs) |
| PL (1) | PL366630A1 (cs) |
| PT (1) | PT1315750E (cs) |
| RU (1) | RU2239642C1 (cs) |
| SI (1) | SI1315750T1 (cs) |
| TW (1) | TWI248941B (cs) |
| WO (1) | WO2002018437A2 (cs) |
| YU (1) | YU15603A (cs) |
| ZA (1) | ZA200301015B (cs) |
Families Citing this family (60)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1409521A2 (en) * | 2001-07-12 | 2004-04-21 | Merck & Co., Inc. | Cyclic peptides as potent and selective melanocortin-4 receptor agonists |
| US7655658B2 (en) | 2001-08-10 | 2010-02-02 | Palatin Technologies, Inc. | Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds |
| US7718802B2 (en) | 2001-08-10 | 2010-05-18 | Palatin Technologies, Inc. | Substituted melanocortin receptor-specific piperazine compounds |
| US7354923B2 (en) * | 2001-08-10 | 2008-04-08 | Palatin Technologies, Inc. | Piperazine melanocortin-specific compounds |
| US7456184B2 (en) | 2003-05-01 | 2008-11-25 | Palatin Technologies Inc. | Melanocortin receptor-specific compounds |
| US7732451B2 (en) | 2001-08-10 | 2010-06-08 | Palatin Technologies, Inc. | Naphthalene-containing melanocortin receptor-specific small molecule |
| WO2003013571A1 (en) | 2001-08-10 | 2003-02-20 | Palatin Technologies, Inc. | Peptidomimetics of biologically active metallopeptides |
| BR0305628A (pt) | 2002-07-09 | 2004-09-08 | Palatin Technologies Inc | Composição farmacêutica para tratar disfunção sexual num mamìfero compreendendo peptìdeo e seu uso |
| US7727991B2 (en) | 2003-05-01 | 2010-06-01 | Palatin Technologies, Inc. | Substituted melanocortin receptor-specific single acyl piperazine compounds |
| US7968548B2 (en) | 2003-05-01 | 2011-06-28 | Palatin Technologies, Inc. | Melanocortin receptor-specific piperazine compounds with diamine groups |
| US7727990B2 (en) | 2003-05-01 | 2010-06-01 | Palatin Technologies, Inc. | Melanocortin receptor-specific piperazine and keto-piperazine compounds |
| WO2004099246A2 (en) * | 2003-05-09 | 2004-11-18 | Novo Nordisk A/S | Peptides for use in treating obesity |
| KR20060026011A (ko) | 2003-05-09 | 2006-03-22 | 노보 노르디스크 에이/에스 | 비만 치료용 펩티드 |
| EP1644022A1 (en) * | 2003-06-19 | 2006-04-12 | Eli Lilly And Company | Uses of melanocortin-3 receptor (mc3r) agonist peptides |
| JP2006527773A (ja) * | 2003-06-19 | 2006-12-07 | イーライ リリー アンド カンパニー | メラノコルチン受容体４（ｍｃ４）作用薬とその用途 |
| US7084111B2 (en) | 2003-06-23 | 2006-08-01 | University Of Florida Research Foundation, Inc. | Melanocortin receptor templates, peptides, and use thereof |
| JP2007532471A (ja) * | 2003-09-30 | 2007-11-15 | ノボ ノルディスク アクティーゼルスカブ | 新規メラノコルチンレセプターアゴニスト |
| US7550602B1 (en) * | 2004-01-14 | 2009-06-23 | Palatin Technologies, Inc. | Small molecule compositions for sexual dysfunction |
| US6974187B2 (en) * | 2004-01-28 | 2005-12-13 | Tachi-S Co., Ltd. | Vehicle seat structure |
| EP1732586A1 (en) * | 2004-03-29 | 2006-12-20 | Eli Lilly And Company | Uses of melanocortin-4 receptor (mc4r) agonist peptides administered by continunous infusion |
| DE602005026380D1 (de) * | 2004-04-08 | 2011-03-31 | Astellas Pharma Inc | Verbindung ws727713 |
| US7709484B1 (en) | 2004-04-19 | 2010-05-04 | Palatin Technologies, Inc. | Substituted melanocortin receptor-specific piperazine compounds |
| CN101052647A (zh) * | 2004-11-04 | 2007-10-10 | 诺和诺德公司 | 用于治疗肥胖的新的肽类 |
| WO2006048452A2 (en) * | 2004-11-04 | 2006-05-11 | Novo Nordisk A/S | Peptides for use in treating of obesity |
| US20080306008A1 (en) * | 2004-11-04 | 2008-12-11 | Nova Nordisk A/S | Peptides for Use in the Treatment of Obesity |
| US20080039387A1 (en) * | 2004-11-04 | 2008-02-14 | Novo Nordisk A/S | Novel Peptides for Use in the Treatment of Obesity |
| CA2609951A1 (en) * | 2005-05-31 | 2006-12-07 | Yissum Research Development Company Of The Hebrew University Of Jerusale M | Backbone cyclized melanocortin stimulating hormone (.alpha.s) analogs |
| EP1893240A2 (en) * | 2005-06-13 | 2008-03-05 | Nastech Pharmaceutical Company Inc. | Transmucosal delivery of peptide derivatives |
| US20070025902A1 (en) * | 2005-07-15 | 2007-02-01 | 3M Innovative Properties Company | Recovery of fluorinated carboxylic acid from adsorbent particles |
| US20080015304A1 (en) | 2006-07-13 | 2008-01-17 | Klaus Hintzer | Aqueous emulsion polymerization process for producing fluoropolymers |
| GB2430437A (en) * | 2005-09-27 | 2007-03-28 | 3M Innovative Properties Co | Method of making a fluoropolymer |
| US7834017B2 (en) | 2006-08-11 | 2010-11-16 | Palatin Technologies, Inc. | Diamine-containing, tetra-substituted piperazine compounds having identical 1- and 4-substituents |
| EP2125862A1 (en) * | 2006-12-29 | 2009-12-02 | F. Hoffmann-Roche AG | Methods for the synthesis of cyclic peptides |
| US20100084343A1 (en) * | 2007-02-16 | 2010-04-08 | Mader Brian T | System and process for the removal of fluorochemicals from water |
| US20080264864A1 (en) * | 2007-04-27 | 2008-10-30 | 3M Innovative Properties Company | PROCESS FOR REMOVING FLUORINATED EMULSIFIER FROM FLUOROPOLMER DISPERSIONS USING AN ANION-EXCHANGE RESIN AND A pH-DEPENDENT SURFACTANT AND FLUOROPOLYMER DISPERSIONS CONTAINING A pH-DEPENDENT SURFACTANT |
| RU2450017C2 (ru) * | 2007-05-25 | 2012-05-10 | Ипсен Фарма С.А.С. | Лиганды меланокортиновых рецепторов, модифицированные гидантоином |
| WO2009011261A1 (ja) * | 2007-07-19 | 2009-01-22 | Tokuyama Corporation | ヒダントイン環を有する化合物及びその製造方法 |
| EP2502907B1 (de) | 2008-03-27 | 2018-08-29 | Grünenthal GmbH | Substituierte 4-Aminocyclohexan-Derivate |
| AU2009228637B2 (en) * | 2008-03-27 | 2013-12-19 | Grunenthal Gmbh | (Hetero-)aryl cyclohexane derivatives |
| EA018630B1 (ru) | 2008-06-09 | 2013-09-30 | Палатин Текнолоджиз, Инк. | Специфичные к меланокортиновым рецепторам пептиды для лечения сексуальной дисфункции |
| TW201002340A (en) * | 2008-06-09 | 2010-01-16 | Palatin Technologies Inc | Melanocortin receptor-specific peptides for treatment of obesity |
| EA020959B1 (ru) | 2009-06-08 | 2015-03-31 | Палатин Текнолоджиз, Инк. | Пептиды, специфичные к меланокортиновым рецепторам |
| WO2010144341A2 (en) | 2009-06-08 | 2010-12-16 | Palatin Technologies, Inc. | Lactam-bridged melanocortin receptor-specific peptides |
| UY32690A (es) | 2009-06-08 | 2011-01-31 | Astrazeneca Ab | Péptidos específicos para receptores de melanocortina |
| JP2013511554A (ja) | 2009-11-23 | 2013-04-04 | パラティン テクノロジーズ，インコーポレイテッド | メラノコルチン−１受容体特異的線状ペプチド |
| BR112012011787B1 (pt) | 2009-11-23 | 2022-03-03 | Palatin Technologies, Inc | Peptídeo cíclico e composição farmacêutica |
| CN105492456A (zh) * | 2013-03-15 | 2016-04-13 | 节奏制药公司 | 肽组合物 |
| GB201416351D0 (en) | 2014-09-16 | 2014-10-29 | Shire Internat Gmbh | Heterocyclic derivatives |
| GB201416352D0 (en) * | 2014-09-16 | 2014-10-29 | Shire Internat Gmbh | Spirocyclic derivatives |
| MA40524A (fr) * | 2014-09-26 | 2021-03-17 | Bayer Pharma AG | Dérivés d'adrénomédulline stabilisés et leur utilisation |
| US11542302B2 (en) | 2015-10-15 | 2023-01-03 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Modulators of melanocortin receptors for the treatment of depression and anxiety |
| WO2017066754A1 (en) | 2015-10-15 | 2017-04-20 | The Arizona Board Of Regents On Behalf Of The University Of Arizona | Compositions and methods for the treatment of depression and anxiety |
| US10899793B2 (en) | 2016-05-27 | 2021-01-26 | Regents Of The University Of Minnesota | Melanocortin ligands and methods of use thereof |
| US20190255142A1 (en) * | 2016-10-17 | 2019-08-22 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Novel modulators of melanocortin receptors for the treatment of depression and anxiety |
| US11124541B2 (en) | 2016-10-18 | 2021-09-21 | Regents Of The University Of Minnesota | Chimeric melanocortin ligands and methods of use thereof |
| CN106496008A (zh) * | 2016-10-20 | 2017-03-15 | 上海毕得医药科技有限公司 | 一种合成4‑(4‑氯苯基)环己酮的方法 |
| CN106496005B (zh) * | 2016-10-20 | 2019-04-09 | 上海毕得医药科技有限公司 | 一种4-(4-氯苯基)环己酮的合成方法 |
| US10745444B2 (en) * | 2017-04-17 | 2020-08-18 | National Tsing Hua University | Cyclopeptide, pharmaceutical or cosmetic composition comprising the same and method for preparing the same |
| US11332499B2 (en) | 2018-08-16 | 2022-05-17 | Regents Of The University Of Minnesota | Cyclic peptides and methods of use thereof |
| CN118530294A (zh) * | 2024-05-10 | 2024-08-23 | 浙江大学 | 一种芳基二胺固载连接子、其前体以及制备方法和应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5811391A (en) | 1994-08-25 | 1998-09-22 | Cytel Corporation | Cyclic CS-1 peptidomimetics, compositions and methods of using same |
| US5858972A (en) | 1996-01-11 | 1999-01-12 | La Jolla Cancer Research Foundation | Antithrombotic agents and methods of use |
| ID30262A (id) | 1999-03-29 | 2001-11-15 | Procter & Gamble | Ligan reseptor melanokortin |
-
2001
- 2001-08-21 YU YU15603A patent/YU15603A/sh unknown
- 2001-08-21 CN CNB018150284A patent/CN100491396C/zh not_active Expired - Fee Related
- 2001-08-21 PT PT01962958T patent/PT1315750E/pt unknown
- 2001-08-21 HU HU0303078A patent/HUP0303078A3/hu unknown
- 2001-08-21 AU AU8402601A patent/AU8402601A/xx active Pending
- 2001-08-21 ES ES01962958T patent/ES2280393T3/es not_active Expired - Lifetime
- 2001-08-21 MX MXPA03001721A patent/MXPA03001721A/es active IP Right Grant
- 2001-08-21 SI SI200130703T patent/SI1315750T1/sl unknown
- 2001-08-21 RU RU2003107921/04A patent/RU2239642C1/ru not_active IP Right Cessation
- 2001-08-21 AU AU2001284026A patent/AU2001284026B2/en not_active Ceased
- 2001-08-21 CZ CZ2003584A patent/CZ2003584A3/cs unknown
- 2001-08-21 AT AT01962958T patent/ATE353918T1/de active
- 2001-08-21 EP EP01962958A patent/EP1315750B1/en not_active Expired - Lifetime
- 2001-08-21 NZ NZ523989A patent/NZ523989A/en unknown
- 2001-08-21 IL IL15457501A patent/IL154575A0/xx unknown
- 2001-08-21 KR KR10-2003-7002931A patent/KR100483300B1/ko not_active IP Right Cessation
- 2001-08-21 JP JP2002523951A patent/JP4217069B2/ja not_active Expired - Fee Related
- 2001-08-21 DK DK01962958T patent/DK1315750T3/da active
- 2001-08-21 DE DE60126624T patent/DE60126624T2/de not_active Expired - Lifetime
- 2001-08-21 CA CA002420058A patent/CA2420058C/en not_active Expired - Fee Related
- 2001-08-21 WO PCT/EP2001/009630 patent/WO2002018437A2/en active IP Right Grant
- 2001-08-21 BR BR0113637-2A patent/BR0113637A/pt not_active IP Right Cessation
- 2001-08-21 PL PL01366630A patent/PL366630A1/xx not_active Application Discontinuation
- 2001-08-23 JO JO2001138A patent/JO2454B1/en active
- 2001-08-27 US US09/939,966 patent/US7045591B2/en not_active Expired - Fee Related
- 2001-08-28 MY MYPI20014025A patent/MY137457A/en unknown
- 2001-08-28 PA PA20018527201A patent/PA8527201A1/es unknown
- 2001-08-28 PE PE2001000859A patent/PE20020483A1/es not_active Application Discontinuation
- 2001-08-28 AR ARP010104096A patent/AR030504A1/es active IP Right Grant
- 2001-08-30 TW TW090121400A patent/TWI248941B/zh not_active IP Right Cessation
-
2003
- 2003-02-05 ZA ZA200301015A patent/ZA200301015B/en unknown
- 2003-02-20 HR HR20030126A patent/HRP20030126B1/xx not_active IP Right Cessation
- 2003-02-20 IL IL154575A patent/IL154575A/en not_active IP Right Cessation
- 2003-02-27 MA MA27059A patent/MA27681A1/fr unknown
- 2003-02-27 NO NO20030916A patent/NO20030916L/no not_active Application Discontinuation
- 2003-03-06 EC EC2003004503A patent/ECSP034503A/es unknown
-
2007
- 2007-05-07 CY CY20071100594T patent/CY1106562T1/el unknown
- 2007-05-30 AR ARP070102336A patent/AR061422A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20030126B1 (en) | Selective cyclic peptides | |
| NO20021399D0 (no) | Kazolinderivater og deres anvendelse som farmasöytika | |
| PT1140916E (pt) | Acetais heteroarilo ciclicos | |
| HUP0301607A2 (hu) | Szelektív neurokinin antagonista hatású nitrogéntartalmú heterociklusos vegyületek, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| IL147651A0 (en) | Isoxazoline derivative and herbicide containing the same as the active ingredient | |
| BG108091A (en) | Quinazolines and mmp-13 inhibitors | |
| HUT74367A (en) | Fungicidal alpha-aryl-substituted cyclic amide derivatives, fungicid compositions containing these as active ingredients and using thereof | |
| TW200745034A (en) | New compounds | |
| TR200102038T2 (tr) | Amid bileşenler | |
| MX2007006173A (es) | Nuevos derivados de piridotienopirimidina. | |
| NZ517404A (en) | Benzopyran derivative | |
| AR045768A1 (es) | Compuestos de cefem y sus sales farmaceuticamente aceptables | |
| HRP20000508B1 (en) | Substituted 2-benzylamino-2-phenyl-acetamide compounds | |
| AP9901578A0 (en) | Sulfonylbenzene compounds as anti-inflammatory/analgesic agents. | |
| ATE57930T1 (de) | Dihydropyridine. | |
| WO2007144769A8 (en) | Aryl- and heteroaryl-ethyl-acylguanidine derivatives, their preparation and their application in therapeutics | |
| MY131762A (en) | Pharmaceutical compounds | |
| BG106937A (en) | Novel indole derivatives | |
| MXPA02007973A (es) | Compuestos de aminoacidos y su uso como inhibidores de nep, ace y ece. | |
| HUP0203383A2 (hu) | Aminofenoxiacetamid-származékok és ilyen vegyületeket tartalmazó gyógyászati készítmények | |
| TWI263639B (en) | Novel tetrazole derivative | |
| DE69903620D1 (de) | Alpha-aminophosphinopeptid-derivate und sie enthaltende zusammensetzungen | |
| BG106048A (en) | 6-[[(aryl and heteroaryl)oxy]methyl]naphthalene-2-carboximidamide derivatives, preparation and therapeutic application thereof | |
| TW200510300A (en) | Amino alcohol compounds | |
| BG103937A (en) | 5-naphthalen-1-yl-1,3-dioxane derivatives, their preparation and application in therapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20090107 Year of fee payment: 8 |
|
| B1PR | Patent granted | ||
| PBON | Lapse due to non-payment of renewal fee |
Effective date: 20090822 |